Combined blockade of VEGFR-3 and VLA-1 markedly promotes high-risk corneal transplant survival.
about
High-risk corneal allografts: A therapeutic challengeIntravital Imaging Reveals Dynamics of Lymphangiogenesis and Valvulogenesis.Inhibition of lymphangiogenesis in vitro and in vivo by the multikinase inhibitor nintedanib.Role of angiopoietin-2 in corneal lymphangiogenesis.Presurgical corticosteroid treatment improves corneal transplant survival in miceEffect of sorafenib in a murine high risk penetrating keratoplasty modelMutation of threonine 34 in mouse podoplanin-Fc reduces CLEC-2 binding and toxicity in vivo while retaining antilymphangiogenic activity.Vascular Endothelial Growth Factor Receptor 1 morpholino increases graft survival in a murine penetrating keratoplasty model.Soluble vascular endothelial growth factor receptor-3 suppresses allosensitization and promotes corneal allograft survival.Involvement of lysosomal degradation in VEGF-C-induced down-regulation of VEGFR-3.Conjunctival lymphatic response to corneal inflammation in mice.Vascular endothelial growth factor-C promotes alloimmunity by amplifying antigen-presenting cell maturation and lymphangiogenesis.Understanding lymphangiogenesis in knockout models, the cornea, and ocular diseases for the development of therapeutic interventions.Integrin Alpha-9 Mediates Lymphatic Valve Formation in Corneal Lymphangiogenesis.Integrin Alpha 9 Blockade Suppresses Lymphatic Valve Formation and Promotes Transplant Survival.Angiopoietin-2 Blockade Promotes Survival of Corneal Transplants.Corneal lymphatic valve formation in relation to lymphangiogenesisCXCL10 suppression of hem- and lymph-angiogenesis in inflamed corneas through MMP13.Expression of Lymphangiogenic Markers in Rejected Human Corneal Buttons after Penetrating Keratoplasty.
P2860
Q26751483-9B3B33BA-3E08-472D-B627-16C77AC2EF8CQ27301422-AA9D507E-F8CD-4B94-ADBB-018645A33816Q33563488-610E7ED2-22FA-4CCE-87C0-C55D86C8F918Q33689659-A8EE642F-27A1-4A2F-BB0F-2B27CF124FB4Q33861559-27149975-554B-4C06-8148-8F9620312E4EQ33914667-E9E71187-ADF1-4AA2-B088-74032BAAAC53Q33947226-976E4713-B51F-4A4F-88C8-02A796BC088AQ33961186-DD47D981-3183-4FE0-80DA-0FCDAEC6B401Q34459026-72BA3C2A-69AC-4BB9-B689-E561996D8952Q34624074-C08F545C-4F26-4D5A-AFCB-657CB90317CEQ35864899-10C9892A-B6F7-4A8D-A25F-22F562EF6090Q35921437-14AEB101-EB52-4536-AC76-60865825DC2EQ36808641-D7692425-DEA4-409C-84C0-0371D85CC9D8Q37013678-6A6FF8E8-004E-4D69-9FFC-8FBB8F2CC9A0Q37394943-8B0614DF-DBA9-4379-B648-CDFEC26DE036Q37583284-6D522851-F8C4-43D2-AAB4-F03474011CDBQ37671066-25FFF765-7BB2-4FE0-AD7C-3B7806D11414Q40169045-7D5AF7C6-0ED0-4C68-B4C5-DF6A98A90107Q54187943-1517BD41-EEAD-4C67-A306-C633210FBE2F
P2860
Combined blockade of VEGFR-3 and VLA-1 markedly promotes high-risk corneal transplant survival.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Combined blockade of VEGFR-3 a ...... k corneal transplant survival.
@ast
Combined blockade of VEGFR-3 a ...... k corneal transplant survival.
@en
type
label
Combined blockade of VEGFR-3 a ...... k corneal transplant survival.
@ast
Combined blockade of VEGFR-3 a ...... k corneal transplant survival.
@en
prefLabel
Combined blockade of VEGFR-3 a ...... k corneal transplant survival.
@ast
Combined blockade of VEGFR-3 a ...... k corneal transplant survival.
@en
P2093
P2860
P356
P1476
Combined blockade of VEGFR-3 a ...... k corneal transplant survival.
@en
P2093
P2860
P304
P356
10.1167/IOVS.11-7454
P407
P577
2011-08-17T00:00:00Z